Diligence memo · auto-generated · as of July 2, 2026

Akros Medical, Inc.

Akros Medical, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Akros Medical, Inc. operates in Healthtech, based in DURHAM.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Akros Medical, Inc. has raised $1.0M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $560K on 2015-12-15.

Most recent recorded round closed around 2018-11-27.

Valuation (modeled)modeled

Provath models Akros Medical, Inc. at approximately $16M (range $291K–$181M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.16× the median modeled value of Pre-Seed Healthtech companies in 2016–2018 (113 peers) — value vs value, same stage and era. Within the normal band (116% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 35 months.

Last raise 7.6 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.2× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 29% of Healthtech peers (2138 compared).

Modeled value ranks above 41% of those peers.

Closest niche peers: HealthTech Solutions, Inc., Nulogix Health, Inc., Caddo Medical Technologies LLC, Markit Medical, Inc., Unique Medical Services, LLC.

Peoplefiled

3 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.